Standard
Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin. / Li, Yongquan; Rantanen, Jukka; Yang, Mingshi; Bohr, Adam.
In:
European Journal of Pharmaceutical Sciences, Vol. 129, 2019, p. 1-9.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Li, Y
, Rantanen, J, Yang, M & Bohr, A 2019, '
Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin',
European Journal of Pharmaceutical Sciences, vol. 129, pp. 1-9.
https://doi.org/10.1016/j.ejps.2018.12.010APA
Li, Y.
, Rantanen, J., Yang, M., & Bohr, A. (2019).
Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
European Journal of Pharmaceutical Sciences,
129, 1-9.
https://doi.org/10.1016/j.ejps.2018.12.010Vancouver
Li Y
, Rantanen J, Yang M, Bohr A.
Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
European Journal of Pharmaceutical Sciences. 2019;129:1-9.
https://doi.org/10.1016/j.ejps.2018.12.010Author
Li, Yongquan ; Rantanen, Jukka ; Yang, Mingshi ; Bohr, Adam. / Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin. In: European Journal of Pharmaceutical Sciences. 2019 ; Vol. 129. pp. 1-9.
Bibtex
@article{e141c3c4f2904431893b3d1a81a2eb39,
title = "Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin",
author = "Yongquan Li and Jukka Rantanen and Mingshi Yang and Adam Bohr",
year = "2019",
doi = "10.1016/j.ejps.2018.12.010",
language = "English",
volume = "129",
pages = "1--9",
journal = "Norvegica Pharmaceutica Acta",
issn = "0928-0987",
publisher = "Elsevier",
}
RIS
TY - JOUR
T1 - Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin
AU - Li, Yongquan
AU - Rantanen, Jukka
AU - Yang, Mingshi
AU - Bohr, Adam
PY - 2019
Y1 - 2019
U2 - 10.1016/j.ejps.2018.12.010
DO - 10.1016/j.ejps.2018.12.010
M3 - Journal article
C2 - 30553059
VL - 129
SP - 1
EP - 9
JO - Norvegica Pharmaceutica Acta
JF - Norvegica Pharmaceutica Acta
SN - 0928-0987
ER -
